
NASDAQ:SIBN
This summary was created by AI, based on 1 opinions in the last 12 months.
Experts seem to be concerned about SI-BONE's financial performance, citing significant losses that the company is currently facing. This recurring theme of financial instability raises alarms regarding the viability of the company and its ability to sustain operations in the competitive market. Analysts are wary of the company's future growth prospects due to the ongoing monetary challenges. While some believe that market conditions may eventually favor SI-BONE, the current reviews lean towards skepticism about its financial health and strategic direction. Overall, the consensus is deeply troubled by the ramifications of continued losses, urging potential investors to tread carefully or seek alternative opportunities.
SI-BONE is a American stock, trading under the symbol SIBN (previously SIBN-Q on Stockchase) on the NASDAQ (SIBN). It is usually referred to as NASDAQ:SIBN or SIBN
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SIBN (previously SIBN-Q on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for SI-BONE.
SI-BONE was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for SI-BONE.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for SI-BONE.
SI-BONE is covered by Stockchase experts and is worth watching.
On 2026-08-13, SI-BONE (SIBN) stock closed at a price of $18.95.
Are losing too much money.